Boundless Ideas Page

Welcome to the Boundless Ideas Page!  This is a place where you can submit ideas for enhancement to Boundless for consideration in future versions.

Novel Targets for Alzheimer’s Disease Treatment Drive Alzheimer’s Disease Pipeline Growth

According to a new research report Alzheimer’s Disease Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments” published by P&S Market Research, Alzheimer’s disease currently exhibits a pipeline with 89 active drug candidates.

 

Alzheimer’s disease pipeline offers novel therapeutic targets for the treatment of Alzheimer’s disease.

 

Download Sample of This Research Report:  https://www.psmarketresearch.com/market-analysis/alzheimers-disease-pipeline-analysis/report-sample

 

The study analyzed that the Alzheimer’s disease pipeline comprises 89 drug candidates in different stages of development.

 

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=alzheimers-disease-pipeline-analysis

 

Some of the key players developing drugs for Alzheimer’s disease are Eli Lilly and Company, Genentech, Inc., Eisai Co., Ltd., and others.

Alzheimer's Disease Pipeline Analysis

  • By Phase
  • By Route of Administration
  • By Target
  • By Company

Scope for Customization

P&S Market Research offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes:

  • Market Forecast – Market analysis and forecast for the drug candidates in the last stage of development
  • Company Profiles – Wider company coverage in terms of detailed analysis or additional company profiles

  

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

  • Guest
  • Jan 8 2018
  • Attach files